SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Comment Letter for Apyx Medical (APYX) — Aug 23, 2012

Apyx Medical Corp
Date: Aug. 23, 2012 · CIK: 0000719135 · Accession: 0000000000-12-045832

AI Filing Summary & Sentiment

File numbers found in text: 001-31885

Date
August 23, 2012
Author
/s/ Louis Rambo for
Form
UPLOAD
Company
Apyx Medical Corp

Letter

August 23, 2012 Via E -mail Gary D. Pickett Chief Financial Officer Bovie Medical Corporation 734 Walt Whitman Rd. Melville, NY 11717

Re: Bovie Medical Corporation Form 10 -K for fiscal year ended December 31, 2011 Filed March 29, 2012 File No. 001-31885

Dear Mr. Pickett :

We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all per sons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Louis Rambo for

Show Raw Text
August 23, 2012

Via E -mail
Gary D. Pickett
Chief Financial Officer
Bovie Medical Corporation
734 Walt Whitman Rd.
Melville, NY 11717

Re: Bovie Medical Corporation
Form 10 -K for fiscal  year ended December 31, 2011
Filed March 29, 2012
File No. 001-31885

Dear Mr. Pickett :

We have completed our review of your filing .  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filing and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the United States.  We urge all per sons who are responsible for the
accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

 /s/ Louis Rambo for

Amanda Ra vitz
Assistant Director

cc (by E -mail): Adam Silvers, Esq.